AMGN - AMGEN INC


333.96
2.470   0.740%

Share volume: 833,663
Last Updated: 12-24-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$331.49
2.47
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 12-31-2023 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 02-14-2025 05-02-2024 08-06-2024 10-30-2024 02-14-2025 05-01-2025 08-05-2025 11-04-2025
Cash flow financing 2.754 B -1.708 B -2.649 B -3.651 B -1.407 B -4.107 B -2.673 B -2.853 B
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow -23.797 B -1.236 B -407.000 M -290.000 M 2.962 B -3.163 B -782.000 M 1.417 B
Net income 767.000 M -113.000 M 746.000 M 2.830 B 627.000 M 1.730 B 1.432 B 3.216 B
Depreciation 1.380 B 1.399 B 1.400 B 1.396 B 1.397 B 1.387 B 1.341 B 1.307 B
Changes in inventories 0.000 -806.000 M 0.000 0.000 0.000 -288.000 M 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -27.089 B -217.000 M -217.000 M -210.000 M -402.000 M -447.000 M -389.000 M -414.000 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 152.000 M 13.000 M 21.000 M 47.000 M -31.000 M -36.000 M -20.000 M 22.000 M
Dividends Paid -1.140 B -1.208 B -1.209 B -1.210 B -1.205 B -1.279 B -1.280 B -1.282 B
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 249.000 M 230.000 M 238.000 M 257.000 M 371.000 M 411.000 M 369.000 M 436.000 M
Cash Change -23.797 B -1.236 B -407.000 M -290.000 M 2.962 B -3.163 B -782.000 M 1.417 B